Klaus Bobacz

Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial

M. Kloppenburg, Roberta Ramonda, Klaus Bobacz et al. · Annals of the Rheumatic Diseases · 2018 · 164 citations

Medicine, Pharmacology, Pharmacotherapy +14

Interleukin-1 is essential for systemic inflammatory bone loss

K Polzer, Leo A. B. Joosten, Jürg A. Gasser et al. · Annals of the Rheumatic Diseases · 2009 · 145 citations

Medicine, Immunology, Pathobiology +17

Activation of p38 MAPK is a key step in tumor necrosis factor–mediated inflammatory bone destruction

Jochen Zwerina, Silvia Hayer, Kurt Redlich et al. · Arthritis & Rheumatism · 2006 · 133 citations

Medicine, Immunology, Pharmacology +17

Toll‐like receptors and chondrocytes: The lipopolysaccharide‐induced decrease in cartilage matrix synthesis is dependent on the presence of toll‐like receptor 4 and antagonized by bone morphogenetic protein 7

Klaus Bobacz, Ilse‐Gerlinde Sunk, Jochen G. Hofstaetter et al. · Arthritis & Rheumatism · 2007 · 116 citations

Life Sciences, Immunology, Orthopaedic Surgery +16

Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro

Klaus Bobacz, Reinhard Gruber, A. Soleiman et al. · Arthritis & Rheumatism · 2003 · 88 citations

Medicine, Cell Biology, Molecular Biology +15